Theravance Biopharma
TBPH
#6972
Rank
NZ$0.77 B
Marketcap
Country
$15.65
Share price
-0.11%
Change (1 day)
2.65%
Change (1 year)

Market capitalization of Theravance Biopharma (TBPH)

Market cap: NZ$0.77 Billion

As of April 2025 Theravance Biopharma has a market cap of NZ$0.77 Billion. This makes Theravance Biopharma the world's 6972th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Theravance Biopharma from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.77 B-7.42%
2024NZ$0.83 B-5.53%
2023NZ$0.88 B-25.65%
2022NZ$1.19 B-0.15%
2021NZ$1.19 B-24.74%
2020NZ$1.58 B-27.72%
2019NZ$2.19 B3.18%
2018NZ$2.12 B-0.02%
2017NZ$2.12 B-11.12%
2016NZ$2.39 B162.83%
2015NZ$0.90 B48.24%
2014NZ$0.61 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Theravance Biopharma was reported to be:

NZ$0.77 Billion
by Nasdaq info icon info icon
NZ$0.77 Billion
by CompaniesMarketCap info icon info icon
NZ$0.77 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$1.67 B 116.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$15.35 B 1,883.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.15 B 566.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.01 B 2,485.06%๐Ÿ‡บ๐Ÿ‡ธ USA